Skip Navigation

VideoCast Maintenance

VideoCast will be undergoing scheduled maintenance on Saturday, Oct 3, starting at 9AM EDT UTC-04:00. During this time, Past Events will be unavailable. The maintenance is expected to last several hours.

We apologize for the inconvenience.

Stakeholder Engagement Workshop on the USG Policy for Institutional Oversight of Life Science's Dual Use Research of Concern

Loading video...

371 Views

Air date: Wednesday, July 22, 2015, 9:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 371 (146 Live, 225 On-demand)
Category: Conferences
Runtime: 05:33:09
Description: On September 24, 2014, the USG released the United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC) [FR Doc No: 2014-22770]. The Policy addresses institutional oversight of DURC, which includes policies, practices, and procedures to ensure DURC is identified and risk mitigation measures are implemented, where applicable. Institutional oversight of DURC is a critical component of a comprehensive oversight system since institutions are the most familiar with the life sciences research conducted in their facilities and are in the best position to promote and strengthen the responsible conduct and communication of DURC.

Learn More >> The White House Office of Science and Technology Policy and the National Institutes of Health will co-host a public workshop on July 22, 2015, for interested stakeholders to discuss implementation of the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern. The purpose of the meeting is to inform and engage stakeholders; collect feedback about resources needed to effectively implement the policy; and discuss stakeholder experiences, challenges, and innovative practices. The workshop will include the sessions below: An interactive case study that will illustrate factors that investigators and institutions consider when determining whether research is subject to the Policy. A series of panels comprised of institutional representatives to share their respective approaches to identifying research subject to the policy, developing risk mitigation plans, and raising awareness and education about DURC. An open forum for participants to share individual stakeholder input on issues relating to interpretation and implementation of the policy.

For more information go to http://www.phe.gov/about/OPP/DURCworkshop/Pages/overview.aspx
Author: NIH Office of Science Policy and the White House
 
CIT Live ID: 16590
Permanent link: https://videocast.nih.gov/watch=16590

Related Videos...

Click Here to Play Video.
08:38:27
NCI Board of Scientific Advisors - March 2005 (Day 1)
[NCI Board of Scientific Advisors]
3/7/2005
Click Here to Play Video.
05:29:18
National Science Advisory Board for Biosecurity - July 2006
[National Science Advisory Board for Biosecurity]
7/13/2006
Click Here to Play Video.
03:56:07
NSABB - National Science Advisory Board for Biosecurity, February 2008 (Day 1)
[National Science Advisory Board for Biosecurity]
2/27/2008
Click Here to Play Video.
05:36:38
National Science Advisory Board for Biosecurity (NSABB)
[National Science Advisory Board for Biosecurity]
12/10/2008
Click Here to Play Video.
05:50:48
Advisory Committee to the Director of the NIH - June 2009
[Advisory Committee to the Director of the NIH]
6/4/2009
Click Here to Play Video.
04:38:11
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders - April 2021
[Advisory Board Meetings and Workshops]
4/23/2021
Click Here to Play Video.
06:34:05
Diagnostics and Disease Management Tools for Use in Underserved Populations: An NHLBI Research & Implementation Workshop (Day 2)
[Conferences]
4/15/2021
Click Here to Play Video.
03:44:30
National Advisory Dental and Craniofacial - May 2021
[Advisory Board Meetings and Workshops]
5/26/2021
Click Here to Play Video.
05:23:12
Pain Consortium Symposium (Day 1)
[Conferences]
5/24/2021
Click Here to Play Video.
05:00:17
Advisory Committee to the Director - June 2021 (Day 1)
[Advisory Committee to the Director of the NIH]
6/10/2021